Lung squamous cell carcinoma targeted NGS panel

Alphabetical Test listing

Lung squamous cell carcinoma targeted NGS panel-Pathology add-on

  
Lung squamous cell carcinoma targeted NGS panel
  
Pathology add-on
  
FOCUS
  
Hot Spot Mutations
Next Generation Sequencing
Oncomine Focus Assay
  
  • BRAF
  • NTRK1
  • NTRK2
  • NTRK3
  

Next Generation Sequencing (NGS) for the detection of alterations in solid tumors is critical for cancer care as these findings can direct the optimal use of targeted therapies for patients.

  

If blocks more than 5 years old are submitted for testing, extraction will be attempted, but if insufficient RNA/DNA is retrieved, testing will be cancelled

  
Tumor tissue
  

Formalin-fixed paraffin-embedded (FFPE) tissue block

  

Cytology slide

  

 Molecular Medicare billing request

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed
  
  • Improper label (unlabeled or mislabeled)
  • Improper storage
  • Interfering substances
  • Slides broken beyond repair
  
AHL - Molecular Diagnostics: D
  
Varies
  
10 business days
  

Next Generation Sequencing

  

No variations detected

  
This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.
  
81210 - BRAF NGS
81194 - NTRK 3 Genes NGS
  
Yes
  

Medical necessity

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed

Molecular Medicare billing request

  
12/07/2020
  
01/08/2021
  
04/01/2021